Solventum announced that Dr. Ryan Egeland, MD, has been named chief medical officer.
Dr. Egeland is responsible for leading Solventum's Global Medical and Clinical Affairs...
ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies for chronic migraine patients, announced the closing of a $66 million Series B financing. The round...
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling technology, announced that Wouter Latour, M.D., has joined...
Spectra Medical Devices, LLC, a portfolio company of QHP Capital, is pleased to announce the closing of its acquisition of XL Precision Technologies Ltd....
ProTom International, a leading provider of compact proton therapy technology that is transforming cancer treatment, is pleased to introduce its new proton therapy system,...
